An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor

American Journal of Perinatology

Volumn 27, Issue 1, 2010, Pages 53-59

  Flick, Amy A ^a   De La Torre, Lesley ^a   Roca, Luis E ^a   Istwan, Niki ^b   Rhea, Debbie ^b   Desch, Cheryl ^b   González Quintero, Victor Hugo ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b Department of Clinical Research ^*  (United States)

Author keywords

Continuous subcutaneous terbutaline; Nifedipine; Preterm labor; Tocolysis

Indexed keywords

NIFEDIPINE; TERBUTALINE;

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NURSING CARE; OUTPATIENT; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; TOCOLYSIS;

ADULT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; RECURRENCE; TERBUTALINE; TOCOLYTIC AGENTS;

EID: 74549196197     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1241734     Document Type: Article

References (23)

1. Raju T N., Higgins R D., Stark A R., Leveno K J. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006 118 1207-1214
2. Goldenberg R L., Culhane J F., Iams J D., Romero R. Epidemiology and causes of preterm birth. Lancet 2008 371 75-84
3. Gazmararian J A., Petersen R, Jamieson D J. et al. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol 2002 100 94-100
4. Iams J D., Johnson F F., Hamer C. Uterine activity and symptoms as predictors of preterm labor. Obstet Gynecol 1990 76 (1 suppl) 42S-46S
5. ACOG Committee on Practice Bulletins. American College of Obstetricians and Gynecologist. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor. Obstet Gynecol 2003 101 (5 Pt 1) 1039-1047
6. Sanchez-Ramos L, Kaunitz A M., Gaudier F L., Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol 1999 181 484-490
7. Carr D B., Clark A L., Kernek K, Spinnato J A. Maintenance oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol 1999 181 822-827
8. de la Torre L, Istwan N B., Desch C et al. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis. Am J Perinatol 2008 25 555-560
9. Lyell D J., Pullen K M., Mannan J et al. Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial. Obstet Gynecol 2008 112 1221-1226
10. Lam F, Gill P J., Smith M, Kitzmiller J L., Katz M. Use of the subcutaneous terbutaline pump for long-term tocolysis. Obstet Gynecol 1988 72 810-813
11. Lam F, Gill P. beta-Agonist tocolytic therapy. Obstet Gynecol Clin North Am 2005 32 457-484
12. Guinn D A., Goepfert A R., Owen J, Wenstrom K D., Hauth J C. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial. Am J Obstet Gynecol 1998 179 874-878
13. Wenstrom K D., Weiner C P., Merrill D, Niebyl J. A placebo controlled randomized trial of the terbutaline pump for prevention of preterm delivery. Am J Perinatol 1997 14 87-91
14. Fleming A, Bonebrake R, Istwan N, Rhea D, Coleman S, Stanziano G. Pregnancy and economic outcomes in patients treated for recurrent preterm labor. J Perinatol 2004 24 223-227 (Pubitemid 38500063)
15. Lam F, Istwan N B., Jacques D, Coleman S K., Stanziano G J. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor. Manag Care 2003 12 39-46
16. Morrison J C., Chauhan S P., Carroll C S. Sr, Bofill J A., Magann E F. Continuous subcutaneous terbutaline administration prolongs pregnancy after recurrent preterm labor. Am J Obstet Gynecol 2003 188 1460-1465 discussion 1465-1467
17. Gilbert W M., Nesbitt T S., Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol 2003 102 488-492
18. Pryde P G., Besinger R E., Gianopoulos J G., Mittendorf R. Adverse and beneficial effects of tocolytic therapy. Semin Perinatol 2001 25 316-340
19. Pryde P G., Janeczek S, Mittendorf R. Risk-benefit effects of tocolytic therapy. Expert Opin Drug Saf 2004 3 639-654
20. Kim A, Shim J-Y. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers. BJOG 2006 113 (suppl 3) 113-115
21. Hill W C. Risks and complications of tocolysis. Clin Obstet Gynecol 1995 38 725-745
22. Elliott J P., Istwan N B., Rhea D, Stanziano G. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy. Am J Obstet Gynecol 2004 191 1277-1282
23. Abenhaim H A., Tremblay V, Tremblay L, Audibert F. Feasibility of a randomized controlled trial testing nifedipine vs. placebo for the treatment of preterm labor. J Perinat Med 2007 35 301-304